News Focus
News Focus
icon url

longtermgems

11/03/15 11:24 AM

#985 RE: dndodd #983

The surgeon takes hand off surgibot only to adjust the camera, and the controls are touch sensitive so when the surgeon takes hands off machine, instruments automatically lock in place, big safety feature.

TITXF has more hype among people because the company itself has received more media attention over the past 7+ years. Titan was hyped as Isrg killer 2009-2011 with their imminent release of AMADEUS, which never happened.

TITXF has been public since 2008, they've received a lot more exposure.

TRXC on the other hand has been a private company up until October 2013.

TRXC has been in stealth mode since its founding in 2006 and hasn't received as much "ISrG killer" hype as TITXF since TITXF has been public for a lot longer than TRXC
icon url

longtermgems

11/03/15 11:29 AM

#986 RE: dndodd #983

Also, if you take the time to listen to the surgeon panel TRXC held at the 2015 SAGES event in April, you will actually realize that surgeons, analysts, device reps are abuzz about the product and company. Listen to their webcast, they had a panel of surgeons who have been using the surgibot answer questions and detail their experience with the machine.

Also, look at their recent sales hire. Paul Zeigler and Steven brodZsn. They have been key sales reps at intuitive surgical since the beginning of intuitive surgical

Do you think these two people would ditch intuitive after a long successful tenure if they didn't see potential in Surgibot and Alf-x??

I strongly suggest you listen to the sages webcast where TRXC talks with the surgeon panel and look at the PowerPoint presentation they during that meeting. It will show you that a lot of surgeons are interest in their products.

On the flip side, every surgeon I asked about TITXF either laughed them off or never heard about them.

I wouldn't put much weight to the "device/sales reps" and "surgeons" who post on TITXF board and claim that everyone they talk to is abuzz about TITXF sport.

Every analyst I've spoken with about TITXF has dismissed them and said, "wake me up when they show a prototype."

TITXF has been all talk, no walk for 7+ years